Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MNTL
Upturn stock ratingUpturn stock rating

Tema Neuroscience and Mental Health ETF (MNTL)

Upturn stock ratingUpturn stock rating
$23.33
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/09/2025: MNTL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit 0.2%
Avg. Invested days 70
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/09/2025

Key Highlights

Volume (30-day avg) -
Beta -
52 Weeks Range 19.86 - 27.39
Updated Date 06/30/2025
52 Weeks Range 19.86 - 27.39
Updated Date 06/30/2025

ai summary icon Upturn AI SWOT

Tema Neuroscience and Mental Health ETF

stock logo

ETF Overview

overview logo Overview

The Tema Neuroscience and Mental Health ETF (MENT) focuses on companies involved in neuroscience, mental health treatments, and related technologies, targeting growth in this evolving sector.

reliability logo Reputation and Reliability

Tema ETFs is a relatively new issuer focused on thematic investing. Their reputation is still building.

reliability logo Management Expertise

The management team has experience in thematic investing and healthcare, but their track record is still being established.

Investment Objective

overview logo Goal

To provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Tema Neuroscience and Mental Health Index.

Investment Approach and Strategy

Strategy: The ETF aims to track the Tema Neuroscience and Mental Health Index, which selects companies involved in the neuroscience and mental health space.

Composition The ETF primarily holds stocks of companies involved in the neuroscience and mental health sectors, including pharmaceuticals, biotechnology, and technology companies.

Market Position

Market Share: Data not readily available due to specificity of the fund and the lack of publicly available information.

Total Net Assets (AUM): Data not readily available due to specificity of the fund and the lack of publicly available information.

Competitors

overview logo Key Competitors

  • XLV
  • IBB
  • XBI
  • ARKG

Competitive Landscape

The ETF industry is competitive, dominated by larger healthcare and biotechnology ETFs. MENT faces competition from broad healthcare ETFs and specialized biotech funds. Its competitive advantage hinges on its targeted focus on neuroscience and mental health. A disadvantage is its smaller size and AUM.

Financial Performance

Historical Performance: Historical performance data is limited due to the ETF's relatively recent inception.

Benchmark Comparison: A relevant benchmark comparison would be against a blended index of healthcare and biotech ETFs; data is limited due to the short trading history.

Expense Ratio: 0.75

Liquidity

Average Trading Volume

The ETF's liquidity can be assessed by its average trading volume, which may vary and influence order execution.

Bid-Ask Spread

The bid-ask spread impacts trading costs, and a narrower spread indicates better liquidity.

Market Dynamics

Market Environment Factors

Factors include advancements in neuroscience, increased awareness of mental health, regulatory changes, and economic conditions impacting healthcare spending.

Growth Trajectory

Growth trends depend on the adoption of new therapies, increased investment in mental health, and the performance of underlying holdings.

Moat and Competitive Advantages

Competitive Edge

MENT's advantage lies in its niche focus on neuroscience and mental health, capturing a growing interest in these areas. This targeted strategy could attract investors seeking exposure to specific companies and technologies. The fund's specialized approach differentiates it from broader healthcare ETFs. However, this narrow focus also introduces concentration risk.

Risk Analysis

Volatility

Volatility will depend on the underlying holdings, which may include growth stocks in the biotech and technology sectors.

Market Risk

Risks include regulatory hurdles, clinical trial failures, competition, and overall market sentiment towards healthcare and biotechnology sectors.

Investor Profile

Ideal Investor Profile

The ideal investor is someone interested in healthcare innovation, particularly in neuroscience and mental health, with a higher risk tolerance.

Market Risk

This ETF is more suitable for long-term investors willing to accept higher risk for potential growth in the neuroscience and mental health sectors.

Summary

MENT provides targeted exposure to the emerging field of neuroscience and mental health. It suits investors seeking growth in this specific area, who accept higher risk and understand the sector's dynamics. While its targeted approach is an advantage, the ETF carries concentration risk and has a limited trading history. The ETF's success relies on innovation and the market's appetite for mental health solutions, and may be more suitable for long-term, higher-risk portfolios.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Tema ETFs website
  • ETF.com
  • Morningstar

Disclaimers:

Investment involves risk, including the potential loss of principal. Past performance is not indicative of future results. This is not investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Tema Neuroscience and Mental Health ETF

Exchange NASDAQ
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.